Kahler Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma (NCT04782687) | US Oncology Research | 2021-09-10 |
| MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma (NCT02057640) | Jason Valent | 2014-05-22 |
Track Kahler Disease automatically
Every clearance here is in the API, with alerts when new ones post.